PQ Group (NYSE: PQG) and Enzymotec (NASDAQ:ENZY) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends.
This table compares PQ Group and Enzymotec’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of current ratings and recommmendations for PQ Group and Enzymotec, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
PQ Group presently has a consensus target price of $19.75, indicating a potential upside of 19.05%. Enzymotec has a consensus target price of $11.75, indicating a potential downside of 0.59%. Given PQ Group’s stronger consensus rating and higher probable upside, equities analysts clearly believe PQ Group is more favorable than Enzymotec.
Insider & Institutional Ownership
58.3% of PQ Group shares are held by institutional investors. Comparatively, 15.7% of Enzymotec shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares PQ Group and Enzymotec’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|PQ Group||$1.06 billion||2.11||-$79.74 million||N/A||N/A|
|Enzymotec||$47.70 million||5.81||-$2.92 million||($0.26)||-45.46|
Enzymotec has lower revenue, but higher earnings than PQ Group.
PQ Group beats Enzymotec on 8 of the 10 factors compared between the two stocks.
About PQ Group
PQ Group Holdings Inc is a global provider of catalysts, specialty materials, chemicals and services that enable environmental improvements. The Company’s products and solutions help companies produce vehicles with fuel efficiency. The Company has developed zeolite-based catalysts to reduce pollutants in diesel engines. The Company’s segments include environmental catalysts and services, and performance materials and chemicals. Environmental catalysts and services segment has three product groups, including silica catalysts, zeolite catalysts, and refining services. Silica catalysts product group sells both the finished catalyst and catalysts supports, for the production of high-density polyethylene (HDPE).zeolite catalysts product group is a supplier of emissions control catalysts as well as a supplier of specialty catalysts, precursors, and formulations. Performance materials and chemicals segment has two product groups, including performance materials and performance chemicals.
Enzymotec Ltd. is a nutritional ingredients and medical foods company. The Company’s technologies, research expertise and clinical validation process enables it to develop solutions across a range of products. The Company operates in two segments: Nutrition segment and VAYA Pharma segment. Both of the Company’s segments offer a range of products that leverage its lipid-related offerings. Its product suite addresses the entire human life-cycle, from infancy to old age, and comprises ingredients in products ranging from infant formula to nutritional supplements, as well as branded medical foods, sold only under a doctor’s supervision. It markets its product portfolio to established global consumer companies and physicians and target large and growing consumer health and wellness markets. The Company’s clinically-validated products include bio-functional lipid-based compounds designed to address dietary needs, medical disorders and common diseases.
Receive News & Ratings for PQ Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PQ Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.